Phase I/II study of ABT-378/ritonavir [lopinavir/ritonavir] in combination with reverse transcriptase inhibitors in antiretroviral naive HIV-infected patients

Trial Profile

Phase I/II study of ABT-378/ritonavir [lopinavir/ritonavir] in combination with reverse transcriptase inhibitors in antiretroviral naive HIV-infected patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 Apr 2008

At a glance

  • Drugs Lamivudine; Lopinavir/ritonavir; Stavudine
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 Apr 2008 Added affiliate, from clinicaltrials.gov record.
    • 02 Apr 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
    • 11 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top